Tom Bollmann

Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

Toby M. Maher, Susanne Stowasser, Yasuhiko Nishioka et al. · The Lancet Respiratory Medicine · 2019 · 104 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis

Daniel Dumitrescu, Christian Nagel, Gábor Kovács et al. · Heart · 2017 · 85 citations · Full text

Medicine, Cardiology, Exercise Testing +12

Repetitive Dosing of Intravenous Levosimendan Improves Pulmonary Hemodynamics in Patients With Pulmonary Hypertension: Results of a Pilot Study

Franz X. Kleber, Tom Bollmann, Mathias M. Borst et al. · The Journal of Clinical Pharmacology · 2008 · 83 citations

Medicine, Pharmacology, Pharmacotherapy +12

Impaired peripheral endothelial function in severe idiopathic pulmonary hypertension correlates with the pulmonary vascular response to inhaled iloprost

Birger Wolff, S Lodziewski, Tom Bollmann et al. · American Heart Journal · 2007 · 57 citations

Veterinary Medicine, Pharmacotherapy, Physiology +12

Tobacco Smoke Exposure in Pulmonary Arterial and Thromboembolic Pulmonary Hypertension

Stephan Keusch, Florian F. Hildenbrand, Tom Bollmann et al. · Respiration · 2014 · 40 citations · Full text

Public Health, Toxicology, Epidemiologic Methods +8